Entirety Biomedical
Entirety Biomedical is a preclinical stage medical device development and manufacturing company founded by a team of industry veterans specializing in bioabsorbable metal implants. These fully absorbable implants are built from the patent pending and Entirety owned Curasorb alloy to revolutionize treatment, improve outcomes, and reduce healthcare costs by eliminating removal procedures and life-threatening complications such as infections by absorbing and restoring tissue to its natural physiology, while maintaining performance of titanium implants. The approach leverages decades of expertise, strategic partnerships, and presents a unique opportunity for a large exit consisting of multiple commercialized product lines, starting with ortho extremities and maxillofacial fixation. FDA clearance and commercialization are expected for multiple product lines: Maxillofacial Fixation, ortho extremities fixation and sports medicine indications. Exit via acquisition is expected between 2027-29 at a minimum revenue multiple of 20x based upon comparable biomaterial implant acquisitions.
Domain
entiretybio.com
Country
United StatesIndustry
Health CareEmployees
1-10
Last Funding
$1.2M
Founded
2021
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Entirety Biomedical use?+
Entirety Biomedical uses 10 technologies including reCAPTCHA, Squarespace, Squarespace Commerce.
What industry is Entirety Biomedical in?+
Entirety Biomedical operates in the Health Care industry.
Where is Entirety Biomedical based?+
Entirety Biomedical is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026